|
1
|
Authors/Task Force Members. Piepoli MF,
Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney M,
Corrà U, Cosyns B, Deaton C, et al: 2016 European Guidelines on
cardiovascular disease prevention in clinical practice: The Sixth
Joint Task Force of the European Society of Cardiology and Other
Societies on Cardiovascular Disease Prevention in Clinical Practice
(constituted by representatives of 10 societies and by invited
experts) Developed with the special contribution of the European
Association for Cardiovascular Prevention & Rehabilitation
(EACPR). Atherosclerosis. 252:207–274. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wilson PW, D'Agostino RB, Parise H,
Sullivan L and Meigs JB: Metabolic syndrome as a precursor of
cardiovascular disease and type 2 diabetes mellitus. Circulation.
112:3066–3072. 2005.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zheng M, Choi SY, Tahk SJ, Lim HS, Yang
HM, Choi BJ, Yoon MH, Park JS, Hwang GS and Shin JH: The
relationship between volumetric plaque components and classical
cardiovascular risk factors and the metabolic syndrome a 3-vessel
coronary artery virtual histology-intravascular ultrasound
analysis. JACC Cardiovasc Interv. 4:503–510. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rivera JJ, Nasir K, Cox PR, Choi E, Yoon
Y, Cho I, Chun EJ, Choi S, Blumenthal RS and Chang HJ: Association
of traditional cardiovascular risk factors with coronary plaque
sub-types assessed by 64-slice computed tomography angiography in a
large cohort of asymptomatic subjects. Atherosclerosis.
206:451–457. 2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
De Rosa R, Vasa-Nicotera M, Leistner DM,
Reis SM, Thome CE, Boeckel J, Fichtlscherer S and Zeiher AM:
Coronary atherosclerotic plaque characteristics and cardiovascular
risk factors-insights from an optical coherence tomography study.
Circ J. 81:1165–1173. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Aggarwal A, Srivastava S and Velmurugan M:
Newer perspectives of coronary artery disease in young. World J
Cardiol. 8:728–734. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kalantzi K, Korantzopoulos P, Tzimas P,
Katsouras CS, Goudevenos JA and Milionis HJ: The relative value of
metabolic syndrome and cardiovascular risk score estimates in
premature acute coronary syndromes. Am Heart J. 155:534–540.
2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rathore S, Terashima M, Matsuo H,
Kinoshita Y, Kimura M, Tsuchikane E, Nasu K, Ehara M, Asakura Y,
Katoh O and Suzuki T: Association of coronary plaque composition
and arterial remodelling: A optical coherence tomography study.
Atherosclerosis. 221:405–415. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Finn AV, Nakano M, Narula J, Kolodgie FD
and Virmani R: Concept of vulnerable/unstable plaque. Arterioscler
Thromb Vasc Biol. 30:1282–1292. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Jang IK, Bouma BE, Kang DH, Park SJ, Park
SW, Seung KB, Choi KB, Shishkov M, Schlendorf K, Pomerantsev E, et
al: Visualization of coronary atherosclerotic plaques in patients
using optical coherence tomography: Comparison with intravascular
ultrasound. J Am Coll Cardiol. 39:604–609. 2002.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Alberti KG, Eckel RH, Grundy SM, Zimmet
PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith
SC Jr, et al: Harmonizing the Metabolic Syndrome: A Joint Interim
Statement of the International Diabetes Federation Task Force on
Epidemiology and Prevention; National Heart, Lung, and Blood
Institute; American Heart Association; World Heart Federation;
International Atherosclerosis Society; and International
Association for the Study of Obesity. Circulation. 120:1640–1645.
2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Jia H, Dai J, Hou J, Xing L, Ma L, Liu H,
Xu M, Yao Y, Hu S, Yamamoto E, et al: Effective anti-thrombotic
therapy without stenting: Intravascular optical coherence
tomography-based management in plaque erosion (the EROSION study).
Eur Heart J. 38:792–800. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tian J, Hou J, Xing L, Kim SJ, Yonetsu T,
Kato K, Lee H, Zhang S, Yu B and Jang IK: Significance of
intraplaque neovascularisation for vulnerability: Optical coherence
tomography study. Heart. 98:1504–1509. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Nishimura S, Ehara S, Hasegawa T,
Matsumoto K, Yoshikawa J and Shimada K: Cholesterol crystal as a
new feature of coronary vulnerable plaques: An optical coherence
tomography study. J Cardiol. 69:253–259. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tearney GJ, Regar E, Akasaka T,
Adriaenssens T, Barlis P, Bezerra HG, Bouma B, Bruining N, Cho JM,
Chowdhary S, et al: Consensus standards for acquisition,
measurement, and reporting of intravascular optical coherence
tomography studies: A report from the International Working Group
for Intravascular Optical Coherence Tomography Standardization and
Validation. J Am Coll Cardiol. 59:1058–1072. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Iribarren C, Go AS, Husson G, Sidney S,
Fair JM, Quertermous T, Hlatky MA and Fortmann SP: Metabolic
syndrome and early-onset coronary artery disease: Is the whole
greater than its parts? J Am Coll Cardiol. 48:1800–1807.
2006.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Iannaccone M, Quadri G, Taha S, D'Ascenzo
F, Montefusco A, Omede P, Jang IK, Niccoli G, Souteyrand G, Yundai
C, et al: Prevalence and predictors of culprit plaque rupture at
OCT in patients with coronary artery disease: A meta-analysis. Eur
Heart J Cardiovasc Imaging. 17:1128–1137. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lee MG, Jeong MH, Kim DH, Lee KH, Park KH,
Sim DS, Yoon NS, Yoon HJ, Kim KH, Park HW, et al: Can metabolic
syndrome predict the vulnerable plaque in patients with stable
angina pectoris? Virtual histology-intravascular ultrasound
analysis. J Cardiol. 59:266–274. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yonetsu T, Kato K, Uemura S, Kim BK, Jang
Y, Kang SJ, Park SJ, Lee S, Kim SJ, Jia H, et al: Features of
coronary plaque in patients with metabolic syndrome and diabetes
mellitus assessed by 3-vessel optical coherence tomography. Circ
Cardiovasc Imaging. 6:665–673. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Barbero U, Scacciatella P, Iannaccone M,
D'Ascenzo F, Niccoli G, Colombo F, Ugo F, Colangelo S, Mancone M,
Calcagno S, et al: Culprit plaque characteristics in younger versus
older patients with acute coronary syndromes: An optical coherence
tomography study from the FORMIDABLE registry. Catheter Cardiovasc
Interv. 92:E1–E8. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Trusinskis K, Juhnevica D, Strenge K and
Erglis A: iMap intravascular ultrasound evaluation of culprit and
non-culprit lesions in patients with ST-elevation myocardial
infarction. Cardiovasc Revasc Med. 14:71–75. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Erhardt L: Cigarette smoking: An
undertreated risk factor for cardiovascular disease.
Atherosclerosis. 205:23–32. 2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Abtahian F, Yonetsu T, Kato K, Jia H,
Vergallo R, Tian J, Hu S, McNulty I, Lee H, Yu B and Jang IK:
Comparison by optical coherence tomography of the frequency of
lipid coronary plaques in current smokers, former smokers, and
nonsmokers. Am J Cardiol. 114:674–680. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bolorunduro O, Cushman C, Kapoor D,
Alexander K, Cuellar-Silva J, Giri S, Robinson V and Ibebuogu UN:
Comparison of coronary atherosclerotic plaque burden and
composition of culprit lesions between cigarette smokers and
non-smokers by in vivo virtual histology intravascular ultrasound.
J Invasive Cardiol. 27:354–358. 2015.PubMed/NCBI
|
|
25
|
Csordas A and Bernhard D: The biology
behind the atherothrombotic effects of cigarette smoke. Nat Rev
Cardiol. 10:219–230. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gili S, Iannaccone M, Colombo F,
Montefusco A, Amabile N, Calcagno S, Capodanno D, Scalone G,
Rognoni A, Omedè P, et al: Effects of statins on plaque rupture
assessed by optical coherence tomography in patients presenting
with acute coronary syndromes: Insights from the optical coherence
tomography (OCT)-FORMIDABLE registry. Eur Heart J Cardiovasc
Imaging. 19:524–531. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kume T and Uemura S: Current clinical
applications of coronary optical coherence tomography. Cardiovasc
Interv Ther. 33:1–10. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lee T, Mintz GS, Matsumura M, Zhang W, Cao
Y, Usui E, Kanaji Y, Murai T, Yonetsu T, Kakuta T and Maehara A:
Prevalence, predictors, and clinical presentation of a calcified
nodule as assessed by optical coherence tomography. JACC Cardiovasc
Imaging. 10:883–891. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gonzalez L and Trigatti BL: Macrophage
apoptosis and necrotic core development in atherosclerosis: A
rapidly advancing field with clinical relevance to imaging and
therapy. Can J Cardiol. 33:303–312. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Janoudi A, Shamoun FE, Kalavakunta JK and
Abela GS: Cholesterol crystal induced arterial inflammation and
destabilization of atherosclerotic plaque. Eur Heart J.
37:1959–1967. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Taruya A, Tanaka A, Nishiguchi T, Matsuo
Y, Ozaki Y, Kashiwagi M, Shiono Y, Orii M, Yamano T, Ino Y, et al:
Vasa vasorum restructuring in human atherosclerotic plaque
vulnerability: A clinical optical coherence tomography study. J Am
Coll Cardiol. 65:2469–2477. 2015.PubMed/NCBI View Article : Google Scholar
|
